BTIG Research Has Lowered Expectations for Aldeyra Therapeutics (NASDAQ:ALDX) Stock Price
Aldeyra Therapeutics (NASDAQ:ALDX – Get Free Report) had its price target lowered by analysts at BTIG Research from $11.00 to $9.00 in a report released on Monday,Benzinga reports. The firm presently has a “buy” rating on the biotechnology company’s stock. BTIG Research’s target price would indicate a potential upside of 368.75% from the stock’s previous […]
More Stories
US Fighter Jet Downed Over Iran, One Crew Member Rescued, Search Ongoing
By Tom Ozimek Search-and-rescue efforts were underway in southern Iran on April 3 after an American fighter jet was shot...
Trump Signals Possible US Operation to Reopen Strait of Hormuz
By Tom Ozimek U.S. President Donald Trump said on April 3 that the United States could “easily” reopen the Strait...
Age of Attraction Season 2? Renewal, Couples, Release Date, and Trailer
After a positive review of the debut of season 1 on March 11, 2026, people are craving more for the...
‘Bob’s Burgers’ Actor Identified as Driver Rescued From Fiery New Hampshire Crash
By Haika Mrema Actor and comedian Eugene Mirman has been identified as the driver rescued from a burning vehicle following...
Trump Says Pam Bondi Is out as His Attorney General
By Matthew Vadum President Donald Trump said on April 2 that Pam Bondi will no longer be the U.S. attorney...
US Military Says More Than 12,300 Iranian Targets Struck So Far
By Jack Phillips The U.S. military has provided an operational update on the month-long war with Iran, announcing that more...